Anniek de Ruijter
LightNews LightNews
banner
deruijter.bsky.social
Anniek de Ruijter
@deruijter.bsky.social
1.5K followers 900 following 11 posts

Professor of Health Law & Policy @AmsterdamLawSchool | & Law for Health and Life |

Board Member @Bureau Clara Wichmann genderequality & strategic litigation | Academic Council @Amsterdam Institute for Global Health

Videos
Political science 34%
Economics 18%
Posts Replies Media Videos

Reposted by Anniek de Ruijter

lawhealthlife.bsky.social
Law for Health and Life @lawhealthlife.bsky.social · Aug 27
After 2 years into our existence, and proud to share our Biannual Report 2022–2024 🎉

👉 170+ publications
👉 €2.4M research funding
👉 Innovated our Master in Health Law & started a Minor in Bioethics & Law
👉 Service to society

Read more: lhl.uva.nl/en/content/n...
#HealthLaw #Impact #UvA
First biannual Report | Law for Health and Life (2022–2024) - LHL
Two years ago, the Law for Health and Life officially began its work as a research centre at the University of Amsterdam. We are proud to now share our first Report.
lhl.uva.nl

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Aug 14
With @PramitiParwani & @katperehudoff.bsky.social, we explored EU pharma regulators’ role in access to medicines in low-income countries. Trust remains one-way, reinforcing dependencies; building regional regulatory capacity is key for global health 💫
jlme-journal.bsky.social The Journal of Law, Medicine and Ethics @jlme-journal.bsky.social · Aug 13
New open access on FirstView: "Trust Beyond Borders: European External Regulatory Influence on Access to Medicines" by Pramiti Parwani, ‪@katperehudoff.bsky.social‬, and @deruijter.bsky.social from the upcoming fall special issue "Public Health, Markets, and Law."
www.cambridge.org/core/journal...
Symposium Articles Trust Beyond Borders: European External Regulatory Influence on Access to Medicines Pramiti Parwani1,2,3 , Katrina Perehudoff1,2,3 and Anniek de Ruijter1,2 1University of Amsterdam, Amsterdam Law School, Law for Health and Life, Netherlands; 2Amsterdam Institute for Global Health and Development, Netherlands and 3Amsterdam Centre for European Law and Governance, University of Amsterdam, Netherlands Abstract European institutions are widely recognized as wielding regulatory power in a globalized market, exporting its standards across borders and between sectors. This paper asks what institutional dynamics catalyze European external regulatory impact on pharmaceutical governance in low- and middle-income countries (LMICs). The research focuses on two European regulatory bodies, the European Medicines Agency (EMA) and the European Patent Office (EPO), and explores the dynamics of their technocratic outreach beyond European borders. We find that trust is a key underlying institutional dynamic facilitating some forms of European external relations. The agencies extend their influence through technical assistance, collaboration, and work-sharing with LMIC regulators, fostering a one-sided relationship of“technocratic trust.” This trust, reinforced by international regulatory frameworks that position the EMA and EPO as“trustworthy” regulators, enables these agencies to expand their regulatory influence beyond Europe. By critically examining the impact of this trust-building on LMICs’ regulatory autonomy, this research contributes to the broader discourse on European regulatory power in global health governance and highlights potential implications for pharmaceutical markets and access in LMICs. Keywords: European Regulatory Bodies; Pharmaceuticals Access; European Medicines Agency (EMA); European Patent Office (EPO); Trust

Reposted by Daniel S. Goldberg, Anniek de Ruijter

jlme-journal.bsky.social
The Journal of Law, Medicine and Ethics @jlme-journal.bsky.social · Aug 13
New open access on FirstView: "Trust Beyond Borders: European External Regulatory Influence on Access to Medicines" by Pramiti Parwani, ‪@katperehudoff.bsky.social‬, and @deruijter.bsky.social from the upcoming fall special issue "Public Health, Markets, and Law."
www.cambridge.org/core/journal...
Symposium Articles Trust Beyond Borders: European External Regulatory Influence on Access to Medicines Pramiti Parwani1,2,3 , Katrina Perehudoff1,2,3 and Anniek de Ruijter1,2 1University of Amsterdam, Amsterdam Law School, Law for Health and Life, Netherlands; 2Amsterdam Institute for Global Health and Development, Netherlands and 3Amsterdam Centre for European Law and Governance, University of Amsterdam, Netherlands Abstract European institutions are widely recognized as wielding regulatory power in a globalized market, exporting its standards across borders and between sectors. This paper asks what institutional dynamics catalyze European external regulatory impact on pharmaceutical governance in low- and middle-income countries (LMICs). The research focuses on two European regulatory bodies, the European Medicines Agency (EMA) and the European Patent Office (EPO), and explores the dynamics of their technocratic outreach beyond European borders. We find that trust is a key underlying institutional dynamic facilitating some forms of European external relations. The agencies extend their influence through technical assistance, collaboration, and work-sharing with LMIC regulators, fostering a one-sided relationship of“technocratic trust.” This trust, reinforced by international regulatory frameworks that position the EMA and EPO as“trustworthy” regulators, enables these agencies to expand their regulatory influence beyond Europe. By critically examining the impact of this trust-building on LMICs’ regulatory autonomy, this research contributes to the broader discourse on European regulatory power in global health governance and highlights potential implications for pharmaceutical markets and access in LMICs. Keywords: European Regulatory Bodies; Pharmaceuticals Access; European Medicines Agency (EMA); European Patent Office (EPO); Trust

Reposted by Anniek de Ruijter

uvalawschool.bsky.social
Amsterdam Law School @uvalawschool.bsky.social · May 21
Hoe kunnen Europese landen beter samenwerken om hun zorgsystemen toekomstbestendig te maken? @deruijter.bsky.social schoof aan bij @bnr.nl om het daarover te hebben 📻 @lawhealthlife.bsky.social‬ https://bit.ly/3YQlOCz

Reposted by Anniek de Ruijter

euronews.com
Euronews @euronews.com · Apr 12
While the euro's rise as a safe haven is promising, sustaining this trend requires more than just fiscal stimulus, S&P Global Ratings' Sylvain Broyer writes in a Euroviews exclusive.
The euro as a safe haven: Is it here to stay?
While the euro's rise as a safe haven is promising, sustaining this trend requires more than just fiscal stimulus, S&P Global Ratings' Sylvain Broyer writes in a Euroviews exclusive.
l.euronews.com

Reposted by Anniek de Ruijter

ascor.bsky.social
ASCoR @ascor.bsky.social · Apr 10
📢 Exciting News!

UvA ELSA Lab AI for health equity, led by Prof. Julia van Weert (ASCoR, Health Communication) and Prof. @deruijter.bsky.social (Health Law), has been awarded €2.3 million in funding from the #NWO (Dutch Research Council)! Congratulations! 🎉

Read more 👇
Amsterdam Center for Health Communication (english) | NWO grant for UvA ELSA Lab AI for health equity
www.healthcommunication.nl

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Apr 1
Happy and proud of this recognition of our ELSA Lab AI for Health Equity with @juliavanweert.bsky.social from @lawhealthlife.bsky.social at @uvalawschool.bsky.social and so many other wonderful researchers, people, organizations and communities🌿🌿 www.uva.nl/content/nieu...
NWO-subsidie voor UvA ELSA Lab AI voor rechtvaardige zorg
De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) heeft 2,3 miljoen toegekend aan een nieuw onderzoeksinitiatief over kunstmatige intelligentie (AI) in de gezondheidszorg. Het ELSA Lab,...
www.uva.nl

Reposted by Anniek de Ruijter

lawhealthlife.bsky.social
Law for Health and Life @lawhealthlife.bsky.social · Mar 7
Congratulations to Dr. @hvkolfschooten.bsky.social for successfully defending her PhD on ‘Patients’ Rights Protection and AI in Healthcare in the EU’ at UVA under the guidance of Johan Legemaate, @deruijter.bsky.social, and Kristina Irion. bit.ly/3F5Qad6
Patient Rights in the Age of AI: Hannah van Kolfschooten Defends Her PhD at the UvA - LHL
On March 6, 2025, Hannah van Kolfschooten from Law for Health and Life defended her dissertation, "Patients’ Rights Protection and Artificial Intelligence in Healthcare in the European Union."
bit.ly

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Mar 1
#zonderdiversiteitgeenzorg
#zondermigratiegeenzorg

Ook in NL is de zorg in groeiende mate afhankelijk van migratie. Hier wordt onvoldoende rekening mee gehouden in ons huidige beleid!

Reposted by Anniek de Ruijter

muschelschloss.bsky.social
Muschelschloss 🌳 @muschelschloss.bsky.social · Feb 24
Ohne Vielfalt keine Pflege.
#Pflegeistbunt

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Jan 25
Last week I spoke with @euronews.com about the potential changing role of the EU in #globalhealth as a result of the US position on the WHO www.euronews.com/health/2025/...
As the US exits the WHO, can the EU fill the gap in global health?
With Donald Trump’s plans to cut ties with the World Health Organisation (WHO), the international agency stands to lose not only $1 billion but one of the most influential actors on global health. Wil...
www.euronews.com

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Dec 18
Last week I spoke with @marianneguenot.bsky.social of the @thelancet.bsky.social about the new Commissioner for Health of the EU from Hungary, Olivér Várhelyi:

What can we expect from this experienced EU law-maker, lawyer and civil servant, who has a history in the EU with some spots on his record?

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Nov 26
‼️in het rapport van @rivm-nl.bsky.social wordt wederom de noodklok geluid over toenemende gezondheidsschade die het gevolg is van een steeds ongezondere voedselomgeving. Samen met @liesbethvanrossum reageerde ik op dit nieuws in @trouw.bsky.social

De tijd van praten aan preventietafels is voorbij⏱️

Reposted by Tamara Hervey, Dorte Sindbjerg Martinsen

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · Nov 24
Together with @martinmckee.bsky.social and @tamarahervey.bsky.social we added the outline of the missing health chapter to the Draghi report in @thelancet.bsky.social reg Europe.

No productivity without strong health systems and healthy people.
martinmckee.bsky.social Martin McKee @martinmckee.bsky.social · Nov 23
Mario Draghi’s report on productivity in the EU had a major omission - health. A healthy workforce and strong health systems are essential prerequisites. @tamarahervey.bsky.social @deruijter.bsky.social & I have provided the missing chapter

www.sciencedirect.com/science/arti...
Health, the missing chapter in the Draghi Report on Europe's future
www.sciencedirect.com

Reposted by Tamara Hervey, Dorte Sindbjerg Martinsen

martinmckee.bsky.social
Martin McKee @martinmckee.bsky.social · Nov 23
Mario Draghi’s report on productivity in the EU had a major omission - health. A healthy workforce and strong health systems are essential prerequisites. @tamarahervey.bsky.social @deruijter.bsky.social & I have provided the missing chapter

www.sciencedirect.com/science/arti...
Health, the missing chapter in the Draghi Report on Europe's future
www.sciencedirect.com

deruijter.bsky.social
Anniek de Ruijter @deruijter.bsky.social · May 28
👇🏼out now, open access 🌿

Reposted by Anniek de Ruijter

lukashetzer.bsky.social
Lukas Hetzer @lukashetzer.bsky.social · Apr 16
We rely on data from a conjoint survey experiment by Roel Beetsma, Brian Burgoon, @francesconicoli.bsky.social ,
@deruijter.bsky.social , and Frank Vandenbrouke complemented with NUTS-2 regional-level measures of crisis impact.
t.co/LS4vp6oRKT
What kind of EU fiscal capacity? Evidence from a randomized survey experiment in five European countries in times of corona
Abstract. Based on a conjoint survey experiment, we explore the support among European citizens for a European Union (EU) budgetary assistance instrument t
t.co